Professional Documents
Culture Documents
available at www.sciencedirect.com
REVIEW
KEYWORDS
Immunostimulants;
-glucan;
Adaptive immunity;
Th1;
Th2;
Th17;
Adjuvants;
Vaccines;
Dectin-1;
Toll Like
receptors;
Shrimp
Abstract The use of immunostimulants has received increased attention due to the discovery
of Toll-like receptors (TLR) or/and pattern recognition receptors (PRR). These receptors have
been found to bind molecules from a range of pathogens including self-molecules. When cell
damage has occurred many of the released molecular structures act as so-called danger
signals possessing pathogen-associated molecular patterns (PAMP). These danger signals often
consist of repeating molecular moieties yielding high molecular weight compounds. Examples
are -glucans and CpG containing DNA, but some danger signals possess low molecular weight
structures. It has been found that the PRR bind unit structures of PAMP, and that PAMP-binding
involves several other humoral and cell membrane proteins, exemplified by the more or less
simultaneous LPS recognition displayed by MD-2, CD-14 and TLR4 on the cell membrane. Also,
the binding of -glucans has been shown to include several different cell membrane receptors.
Several immunostimulants are commercially exploited in aquaculture as feed additives. This
applies to -glucans, alginates and nucleotides. Despite their use as feed additives no targeted
approach has been conducted to include PAMP as adjuvants in fish vaccines. Interestingly, most
of the PAMP studied activate antigen-presenting cells together with nave T cells into dendritic
cells and Th1 or Th2 cells [1]. In turn, this may activate Th1 and Th2 immune responses with production of Th1 or Th2 signature molecules such as IFN-gamma and IL-4, respectively [2e4]. This
review will mainly focus on binding characteristics of -glucans, their effects on T helper cell differentiation, effects on functional levels, gene expression profiles and application of the commonly used -glucan in the aquaculture sector. In addition, -glucans show promises in shrimp
aquaculture by inducing disease resistance, this review will also highlight the use and the effects
of -glucans in experimental models.
2008 Elsevier Ltd. All rights reserved.
-glucans in aquaculture
Introduction
A number of immunostimulants has molecular architecture
possessing repeating units of a certain moiety such as
glucose in -glucans and (deoxy)riboses in DNA/RNA, fatty
acid chains in bacterial lipopolysaccharides (LPS) and
certain lipoproteins. Such patterns are abundant in microbial communities of prokaryotes, and can be termed
pathogen-associated molecular patterns, PAMP, if they
initiate inflammatory responses. Interestingly, most of the
PAMP studied activate antigen-presenting cells together
with naive T cells into dendritic cells and T helper cells [1e
4]. During microbial breakdown/degradation, a number of
PAMP may be released that would initiate inflammatory responses upon receptor binding and intracellular activation
of signal transducers and transcription factors. The exact
composition of released danger signals would be decisive
for the out-put gene transcription leading to synthesis and
release of pro-inflammatory cytokines. Immunostimulants
have been used as feed additives for many years in aquaculture, and yeast -glucan may be the one with the longest
track record. Homo-polysaccharides, consisting of one sugar,
are described by use of the suffix an. Thus a poly-glucose
(poly-glucopyranose) is termed glucan. Other carbohydrates may be hetero-polysaccharides that may contain
several different constituent residues. (1,3)-D-glucans
(-glucans) are the most commonly used term for homopolysaccharides that has (1,3)-D-linkages in the backbone,
and may also possess -D-glucosidic linkages at position 6 in
different, often repeating units (branches). In nature, -glucans are widespread and are found in plants, algae,
bacteria, yeast and mushrooms. -glucans possess differences in molecular weights and degree of branching. Yeast
-glucan is a particulate carbohydrate that consists of glucose and mannose and is a major constituent of the cell
membrane. Of the major fish feed producers, Skretting
and Ewos include yeast -glucan in their fish feed assortments, while BioMar includes bioactive alginate.
Growth performance
Besides the information presented in comprehensive review
articles on immunostimulants [5], several new reports have
described the effects of -glucans on growth performance
in fish. It has been found that -glucans such as yeast glucans obtained from Saccharomyces cerevisiae incorporated
in fish feed increase the growth rate of certain species of
fish at certain environmental conditions [6e9]. However,
in other scientific experiments no significant growth
increase has been found after feeding fish with different
-glucans [10e12]. It appears that a growth increase is
dependent on the amount of -glucan incorporated in the
diet, duration of feeding, environmental temperature and
the species under study. To obtain increased growth performance, feeding strategies should be developed for each fish
species with respect to -glucan dose and duration. In addition, soluble or particulate -glucans may confer different
responses since the intestine only absorb soluble -glucans.
There are no indications that particulate -glucans are
taken up by the fish intestine or digested by -glucan
degrading enzymes thereby being nutritious. Feed additives
385
such as bioactive alginates, enriched with mannuronic acid
residues, have also been reported both beneficial and
detrimental with respect to weight increase and protein
turnover in fish larvae and juveniles [13e15]. Dietary nucleotides may induce weight gain in fish although it seems that
it is likely that species and dose dependencies occur
[11,16,17]. Following on, the weight of salmon given formulated feed with 0.01% and 0.03% w/w Aeromonas salmonicida LPS for 62 days exhibited statistically higher weight
compared to control fish. At the same time, the weight of
fish that received 0.1% LPS did not differ from controls
[18]. To date, there are no plausible explanations for the
growth enhancing effects displayed by diets containing
immunostimulants. One hypothesis may include a local
intestinal inflammatory response, after administration
that induces resistance against pathogens - that otherwise
would result in decreased weight gain and maybe disease.
Evidently, to assess the growth enhancing effects of immunostimulants more sophisticated analysis must be companioned. This should be highly feasible due to the advanced
genomic tools available for gene expression analysis.
386
Table 1
Agent (glucan)
Fish species
Administration
Effects
Reference
EcoActiva
Pink snapper
(Pagrus auratus)
Oral
Macrophage respiratory
burst[
Growth[
[6]
-glucan
Rohu (Labeo
rohita Hamilton)
Oral
Superoxide anion[
Phagocytosis[
Lysozyme[
Haemolytic complement[
Serum bactericidal activity[
Specific growth[
[7]
-1,3-glucan
Large yellow
croaker (Pseudosciaena
crocea)
Oral
Lysozyme[
Fish growth[
Alternative complement
pathway/
Phagocytosis[
Respiratory burst[
Protection against Vibrio
harveyi[
[8]
-glucan (barley)
Rainbow trout
(Oncorhynchus
mykiss)
Oral
GrowthY
Respiratory burst/
Lysozyme/
TNF-a/
IHNV neutralising
antibody[
Survival IHNV[
[9]
-glucan
Nile tilapia
(Oreochromis
niloticus)
Oral
Lysozyme/
Agglutination antibody
titres/
[10]
Yeast -glucan
Sea bass
(Dicentrarchus
labrax)
Oral
Serum complement
activity[
Serum lysozyme[
Gill and liver heat shock
protein[
[11]
Whole-cell/yeast
subcomponents
Channel catfish
(Ictalurus
punctatus)
Oral
Growth/
Plasma lysozyme/
Spontaneous haemolytic
complement/
Bactericidal activity/
Survival Edwardsiella
ictaluri infection/
[12]
-1,3,1,6-glucan
Atlantic cod
(Gadus morhua)
Oral
Rainbow trout
Oral
[15]
Oxidative burst/
Pinocytosis/
Lysozyme/
Alternative complement
activation/
Con A lymphocyte
stimulation[
Antibody response[
[20]
-glucans in aquaculture
387
Table 1 (continued)
Agent (glucan)
Fish species
Administration
Effects
Reference
-1,3-glucan
(Saccharomyces
cerevisiae) LPS
Carp (Cyprinus
carpio)
Intraperitoneal
/oral
Superoxide anion[
Adjuvant effect[
Classical/alternative
complement/
Resistance Aeromonas
hydrophila[
[26]
-1,3-glucan
Rohu
Oral
Resistance to Aeromonas
hydrophila[
Leucocyte numbers[
Phagocytic index[
Serum bactericidal activity[
[22]
-1,3-glucan
Rohu
Oral
Antibody response[
Resistance against
Edwardsiella tarda[
[23]
Asian catfish
(Clarias
batrachus)
Oral
Antibody response[
Protection against
Aeromonas hydrophila[
[24]
Asian catfish
Oral
Superoxide anion[
Myeloperoxidase[
Phagocytic activity[
Haemagglutination
(immunocompromised)[
[25]
Carp
Intraperitoneal,
bath, oral
[21]
Mushroom glucan
Intraperitoneal
Adjuvant[
Antibody response[
Resistance against
Aeromonas hydrophila/
[30]
-1,3,1,6 yeast
glucan
Atlantic salmon
(Salmo salar)
Intraperitoneal
Adjuvant[
[33]
-1,3-glucan
Atlantic salmon
Yellowtail
(Seriola
quinqueradiata)
Intraperitoneal
Adjuvant[
[34]
[38]
-1,3-glucan
(laminaran)
Rainbow trout
Intraperitoneal
IL-11[
IL-12[
IL-6[
C3-1[
C3-2[/Y
C3-3Y
[56]
388
rainbow trout was evaluated with macrophage activities,
lysozyme and complement activation. In addition, antibody
responses were analysed after vaccination with formalinkilled Yersinia ruckeri [20]. The non-specific immune
parameters were evaluated at the end of a 2-week feeding
period and 4 weeks later. A significant enhancing effect of
dietary -1,3/-1,6-glucan was found on concanavalin Ainduced proliferation of lymphocytes and the antibody
response after vaccination against Y. ruckeri. But glucan
showed no effect on oxidative burst, pinocytosis, lysozyme
activity and alternative complement pathway activation.
Carp (Cyprinus carpio) were given -glucan by the oral
route before vaccination with Aeromonas hydrophila. The
antibody titre was slightly increased. Orally administered
glucan did not result in changes of the alternative complement pathway [21]. -Glucan was administered to Labeo
rohita fingerlings through different dietary doses for 56
days. Leucocyte counts and both cellular and humoral
immune parameters were evaluated at 2 weeks intervals
[7]. Administration of the highest dose (500 mg -glucan
per kg diet) resulted in a reduced white blood count
compared to fish fed 250 and 100 mg. Maximum superoxide
anion production and phagocytic activity in head kidney
macrophages were found in fish fed 500 mg and 250 mg
-glucan per kg diet (for 42 days), respectively. Haemolytic
complement activity was significantly higher in fish stimulated with -glucan except the 500 mg per kg dose. The
lysozyme and bactericidal activity were highest at a dose
of 250 mg -glucan per kg dry diet fed for 42 days. It is
known that -glucans and LPS may activate the alternative
pathway of complement. Indeed, an intraperitoneal injection of LPS (e.g., 5 mg LPS kg body weight1) has shown
to be exhaustive of the haemolytic activity of complement
in the spotted wolffish (own observation). On the other
hand, whether activation of haemolytic complement activity following oral administration of immunostimulants is
beneficial in terms of disease resistance remains to be
addressed.
Adaptive immunity
T helper cells and differentiation
During an immune response, professional antigen presenting cells (APC) endocytose, e.g., bacteria or viruses, that
undergo processing, then travel from the site of infection to
other lymphoid tissues/organs where antigen presentation
occurs. This allows nave CD4 T cells that express specific
TcRs against the peptide/MHC complex to be activated.
When a Th cell encounters and recognises the antigen on
an APC, the TcReCD3 complex binds strongly to the peptideeMHC complex present on the surface of professional
APC. CD4, a co-receptor of the TCR complex, also binds
to a different section of the MHC molecule. With the assistance of different kinases associated to TcR, CD3 and CD4
and a phosphatase present on the intracellular section of
CD45 (common leucocyte antigen), activation of biochemical pathways in the cytosol of the Th cell occurs. These active pathways are known as signal 1 of T cell activation, as
it is the first and primary pro-activation signal in a Th cell.
Following a re-stimulation with same antigen memory T
cells use the same TCR pathways to become re-activated.
The signal 2 step involves verification step that is a protective measure to ensure non-self response, and involves an
interaction between CD28 on the CD4 T cell and the proteins CD80 (B7.1) or CD86 (B7.2) on the professional APCs.
Both CD80 and CD86 activate the CD28 receptor. These proteins are also known as co-stimulatory molecules. Once
both signals 1 and 2 are active within the helper T cell,
the cells are able to proliferate by releasing a potent T
cell growth factor called interleukin-2 (IL-2) that also acts
-glucans in aquaculture
in an autocrine way by binding to up-regulated IL-2 receptors (CD25) on both CD4 and CD8 T cells. This binding,
when a critical number of receptors are triggered, leads
to cell division and cytokine production. After many cell
generations, the Th cell progenitors differentiate into
effector Th cells, memory Th cells, and regulatory Th cells.
Effector Th cells are cells that secrete cytokines, proteins
or peptides that stimulate or interact with other leucocytes, including Th cells.
Effector T cell responses
The T cell response generated (including cytokine
production) may be essential for a successful outcome
from vaccination. Understanding exactly how helper T cells
respond to infection is of major interest in immunology and
such knowledge may be very useful to increase the
effectiveness of vaccination. Proliferating helper T cells
that develop into effector T cells differentiate into two
major subtypes of cells known as Th1 and Th2 cells (also
known as Type 1 and Type 2 helper T cells, respectively).
While it is established that certain cytokine patterns favour
differentiation of Th into Th1 or/and Th2 cells after
activation of nave T cells, it is not fully clear how the
various patterns are decided and how the cytokines
interplay with each other. In a rather schematic and simple
way, Th1 and Th2 responses are facetted by different
cytokine profiles. The presence of relatively high amounts
of interferon gamma (IFN-g) and tumor necrosis factor beta
(TNF-) favours a Th1 response characterised by an increased activity of the cellular arm of defence where killing
efficacy of macrophages and proliferation of CD8 T cells
(CTL) are increased [27]. IFN-g increases the production
of IL-12 by dendritic cells and macrophages in an autocrine
manner, to produce more IFN-g in helper T cells promoting
a stronger Th1 response. IFN-g inhibits IL-4, an important
cytokine within the Th2 response. IL-4, IL-5, IL-6, IL-10
and IL-13 are all involved in a favoured Th2 response that
stimulates B cells into proliferation, antibody class switching and to increase antibody production. Of these interleukins, IL-10 inhibits the transcription of a variety of
cytokines such as IL-2 and IFN-g by all Th cells, and IL-12
in dendritic cells and APC, but continues to stimulate
plasma cells to produce antibodies. While Th1 and Th2 responses are pro-inflammatory, a Th3 response is believed
to be immune suppressive by increased production of IL10 and TGF- of Th1/Th2 cells at a later stage in inflammation [27]. Manifestation of the different Th responses in fish
is still in its infancy due to lack of suitable Th signature antibodies such as antibodies against fish IL-12 and IL-4. However, at a transcriptome level many of these signature
genes could be analysed and quantified.
389
Adjuvanted vaccines typically work through three principal
modes of actions: (1) through increase of antigen uptake
and presentation of antigens (oil emulsion, liposomes,
etc.), (2) by a danger effect (cholera toxin, CpG-ODNs,
LPS), and (3) through signal 2 action (co-stimulation; costimulatory molecules, cytokines, etc.). The use of adjuvants has been largely empirical but today we are seeing
the empirical approach being superseded by a rational
design where one strategy is to deliver an inert antigen in
the context of a danger signal [3]. Oil adjuvants mediate
their danger signal in forms of varying degrees of tissue
damage. In salmon they alarm the immune system likely
by causing tissue damage at the injection and depot site,
the consequence being scarring and adhesions [28,29].
The danger effects may be initiated after ligand binding
by Toll-like receptors.
Some approaches have been made to include immunostimulants as vaccine adjuvants in fish to increase vaccine
potency and efficacy. Increased vaccine potency in terms of
increased antibody response was observed after injection of
-glucan adjuvanted inactivated A. hydrophila vaccine [30].
Although not addressed in this study, the mushroom -glucan
they obtained and applied, resulting in the elevated antibody response, was probably a water-soluble -glucan.
Water-soluble -glucans, often obtained from fungi, have
been thoroughly investigated with respect to biological effects in many mammalian species [31]. Overall, the effects
-glucans exerted include increased mitogenicity, stimulation of hematopoietic stem cells, activation of complement
pathways, and activation of lymphocytes, macrophages,
dendritic cells, NK cells, Th cells, and cytotoxic T cells as
reported in mammalian experimental models. However,
some substances may down-regulate certain inflammatory
responses thus being novel as anti-inflammatory drugs.
-glucans as adjuvants
Modern aquaculture would have been impossible without
the use of injectable vaccines against common diseases.
However, the use of oil emulsions as adjuvants may cause
major drawbacks in terms of unwanted effects such as
internal organ adhesions, melanin deposits, effects on
growth and skeletal deformations. As advocated in
a state-of-the-art review: Although the majority of the
farmed fish seems to possess side effects within acceptable
limits, given the pros of vaccination e it is evident that
some fish possess unacceptable levels of side effects [32].
Adhesions and skeletal deformations are probably the side
effects with the most important implications for animal
welfare and ethics. This addresses the need to develop immunization strategies using milder adjuvants such as glucans or other immunostimulants. Early findings by Rrstad et al. (1993) described protective response of yeast
particulate -glucan adjuvanted A. salmonicida vaccine in
Atlantic salmon [33]. Similar protection was also found applying yeast -glucan in combination with A. salmonicida
bacterin in protection against furunculosis [34]. Following
on in another study, Japanese flounder were fed formalinkilled E. tarda cells together with curdlan (a linear gelling
-glucan), and were assessed for specific antibody response. No increased antibody response was observed
390
although the survival against live E. tarda experimental
challenge was higher than in fish fed the control diet
[35]. This indicated that there was no correlation
between vaccine potency and efficacy. Other defence
mechanisms such as activation of the cellular defence
may have been activated. On the contrary, Midtlyng et al.
(1996) reported no significant protective effects of yeast
-glucan adjuvanted vaccine followed by experimental
challenge with A. salmonicida [36]. Their explanation was
that a high infection pressure in a given challenge experiment was inferior when looking for effects of -glucan adjuvanted vaccines. Following this, absence of adjuvanticity
of yeast -glucan administered with Streptococcus bacterin
to turbot has been reported [37]. Kawakami and co-workers
reported an absence of adjuvant action by using yeast
particulate -glucan co-injected with Pasteurella piscicida
vaccine [38]. Also oral application of yeast -glucan
followed by vaccination with Streptococcus iniae did not
confer protection against S. iniae challenge [10]. Interestingly, zymosan has been found to increase vaccine potency
when co-administered with a HIV-1 DNA vaccine to mouse
[39]. Whether this also applies to fish remains unknown,
but it opens up for applying non-genetic/non-nucleosidic
adjuvants in combination with e.g., VHS and IHN DNA vaccines in aquaculture, especially to DNA vaccines not proven
efficacious enough to induce full protection. Apparently,
due to the conflicting results obtained by -glucans to
increase vaccine potency and efficacy it seems that more
research is highly warranted in terms of dose, duration,
experimental models, and a comprehensive study focusing
on what molecular features (molecular weight, conformation, water-solubility and charge) may be the most potent
one for application to aquaculture systems. In addition,
there may be species-to-species variation with regard to
biological effects, and differential effects against different
pathogens.
-glucan receptors
Non-TLR -glucan receptors
It has been hypothesised that collaboration among
different membrane receptor families, as well as with
non-classical opsonins and protein cascades such as complement, is likely to be an important mechanism to
enhance affinity of binding and specificity [40]. Several
different receptors have been reported to bind -glucans,
these are the scavenger receptors (SR), complement receptor 3 (CD11b/CD18), dectin-1 and TLR2/6. All being innate
receptors but dectin-1 and TLR2/6 are also highly involved
in adaptive responses. There are at least three classes of SR
(SR-A, SR-B and SR-C) based on their structural characteristics. Most of the SR are non-opsonic receptors that display
low-affinity and promiscuous binding to many polyanionic
and modified substances. Although they may bind anionic
-glucans (sulphated -glucans either made chemically or
found in certain algae), they are not considered to be
involved in -glucan binding and internalization. Dectin-1,
belonging to a non-classical C-type lectin-like family that
predominantly binds protein ligands, has been considered
to be the major -glucan receptor [41]. In mouse, dectin1 is expressed on neutrophils, alveolar macrophages, and
-glucans in aquaculture
observed in carp [50], while CR3 gene(s) has not been cloned
and fully sequenced yet in any fish species.
Lactosylceramide
Lactosylceramide has been found on leucocytes and endothelial cells, and is a glycolipid containing a hydrophobic
ceramide lipid and a hydrophilic sugar component. It may
bind specifically -glucans with concomitant production of
reactive oxygen metabolites [51,52]. It is not known
whether such binding may affect APC and T cell activities.
Toll-like -glucan receptors
Formerly, it has been widely acknowledged that fungal cells
and zymosan, both consisting of many different molecular
moieties, may bind TLR2 and TLR4 facilitating myD88
dependent intracellular signalling that induce cytokines
favouring Th1 cell differentiation [53]. Zymosan, that is
obtained from yeast cell walls is composed of insoluble glucans and mannan, and have been utilized in numerous
experiments mainly due to its ability to activate macrophages. Lately, it has been questioned that impurities by,
e.g., bacterial lipopolysaccharides may be decisive for activation of TLR4 [52]. To support this, a recent review has
pointed out that the content of mannans, chitins, proteins
and lipids in zymosan may interfere with the interpretation
of results. Lately, the stand-alone activity of dectin-1 and
the cooperation of dectin-1 with TLR2 have been proposed
to be the major and most important events inducing cell
signalling [54].
391
for activating immune responses adapted to the type of infectious agent [58]. Th1 cells respond to produce IFN-g that
activate APC, and induce B cells to start production and
release of IgG2 isotype antibodies. The Th1 response is particularly effective against eradication of intracellular pathogens. The other arm, Th2, is supported by production of
IL-4 and IL-5 and may activate humoral components and is
especially protective against parasitic infections. Upon receptor binding TLR agonists may program, already at the
first stage, the APC to favour a Th1 or Th2 response
due to certain intracellular signalling cascades resulting in
gene transcription and cytokine production. The APC express the broadest repertoire of TLR through which they
can recognise and bind a high number of different microbial
products [59]. After TLR ligand binding immature APC (e.g.,
DC) may go through maturation steps and migrate to secondary lymphoid organs concomitant with high MHC and
co-stimulatory expression essential for T cell priming. DCs
may produce, dependent of microbial products or IFN-g
and subsequent CD40L provided by T cells, significant IL12 that push the response towards a Th1 bias [59]. In
most circumstances infectious agents contain an array of
different Toll-like agonists. Most of them induce a Th1
bias, but TLR2 and TLR5 agonists may skew the response
into a Th2. Some of these substances may synergize and increase the potential to trigger nave T cells due to a very
high IL-12 production after binding to DCs. Such high IL-12
(IL-12p70) production has been observed after treating human differentiated monocytes (akin to DC) with a mixture
of LPS (TLR4 agonist) and R848 (TLR7) [60]. Even higher production was observed when IFN-g and CD40L were added.
This effect was temporally sustained even up to 24 h. In
a commercial fish vaccine, including up to six different inactivated pathogens, there are numerous different PAMP
that may serve as PRR agonists that alone or synergistically
can induce certain effects on APC/DCs. What the immunological effects are in terms of APC/DC response together
with their effects on T cell response polarisation is an
open issue for further research. Preliminary results obtained in our laboratory suggest that -glucan (Dectin-1,
TLR2/4 agonist) induces salmon spleen IFN-g gene transcription in vivo supporting a Th1-like response. This was
compared with saline injected controls. Anyhow, more targeted and sophisticated experiments must be performed to
find out whether there are functional Th1, Th2, Treg and
Th17 responses in fish similar to higher vertebrates. Clearly,
more monoclonal antibodies for use in cell sorting/flow cytometry combined with functional in vitro cell assays and
gene expression analysis will solve some of these fundamental issues of innate and adaptive fish immunology.
Importantly, the development of vaccines against intracellular pathogens, being the most challenging disease agents
in aquaculture nowadays, should be based on fundamental
immunology rather than trial and error empirical examination of vaccines.
Immunomodulation in shrimp
b-Glucan has been used to enhance resistance in crustacea
against both viral and bacterial infections. The white spot
syndrome (WSS) is the major disease of shrimp in India,
392
Southeast Asia and the Southern and Central America. The
etiological agent is a DNA virus that consists of at least five
major proteins, of which three are localised to the
nucleocapside and two to the envelope [75]. The WSSV
causes high mortality in many cultured shrimp species including black tiger shrimp (Penaeus monodon) and kuruma
shrimp (Penaeus japonicus). Administration of b-1,3-glucan
has been shown to improve the survival of black tiger
shrimp when challenged with WSSV [61e63]. Post larval
and juvenile shrimps were fed diets containing 2 g kg1
for 10e20 days. Following challenge with WSSV, mortality
was significantly lower in the glucan-fed shrimps. None of
the un-treated shrimps survived longer than 4 days. By contrast, some of the glucan-treated larvae (12%) and some of
the juveniles (20%) were still alive at day 6 and were reared
for another 120 days [61]. In another study P. monodon
were fed diets with different levels of b-1,3-glucan from
Schizophyllum commune and then challenged with injection of WSSV [63]. The survival rate of shrimps fed the
diet containing 10 g kg1 was significantly higher on day 9
than the other groups (0, 1, 2 and 20 g kg1). Haemocyte
phagocytic capability, phenol oxidase activity, superoxide
anion and superoxide dismutase activity were significantly
enhanced after oral b-1,3-glucan administration [63]. Sritunyalucksana et al. [73] investigated both in vivo and in vitro
stimulation of the black tiger prawn by peptidoglycan, LPS
and the b-1,3-glucan laminarin. In this study, laminarin
failed to activate the prophenoloxidase, agglutinin and antibacterial activity. Explanation of this lack of effect is uncertain because b-1,3-glucans have been reported to be
a specific activator of prophenoloxidase in several investigations [73].
Huang and Song injected a b-1,3-1,6-glucan from bakers
yeast (S. cerevisiae) in spawners of P. monodon. Larvae
from these glucan-stimulated spawners seemed to be better protected against challenge with the WSSV. This surprising result is the first indication of a maternal transmission
of immunity in invertebrates [67]. Not well-characterised
methanol extracts of five different herbal medicinal plants
were included in diets for the black tiger shrimp [66]. After
25 days of feeding, the shrimps were challenged intramuscularly with WSSV. The group containing 0.8 g kg1 herbal
extracts in the feed resulted in significantly enhanced
survival. However, the active component in these extracts
is not determined.
Crustaceans have mechanisms to recognise cell wall
components of bacteria and fungi. Examples are b-1,3glucan binding protein (GBP) [72] in the black tiger shrimp
and lipopolysaccharide and b-1,3-glucan (LGBP) in white
shrimp (Litopenaeus vannamei) [64]. The GBP is constitutively expressed in haemocytes and shrimps injected with
a b-1,3-glucan (curdlan) or heat-killed Vibrio harveyi did
not result in altered mRNA expression during the first 12 h
after injection [72]. In the white shrimp, a lipopolysaccharide and b-1,3-glucan binding protein cDNA was cloned from
the haemocyte and hepatopancreas. Expression of this
protein was enhanced in haemocytes 3 and 6 h after Vibrio
alginolyticus injection [64].
Another shrimp species called the kuruma shrimp
(P. japonicus) is also susceptible to the WSSV [70]. In the
study shrimps were intramuscularly (i.m.) injected once
with inactivated WSSV alone or in combination with b-1,
-glucans in aquaculture
Table 2
393
Agent
Species
Administration
Effects
Reference
b-1,3-glucan
Schizophyllum
commune
b-1,3-glucan
Schizophyllum
commune
b-1,3-glucan
Schizophyllum
commune
Lactobacillus
probiotics
Immunostimulant
herbs
b-1,3-1,6-glucan
insoluble
(bakers yeast)
Schizophyllan
Oral
Reduced mortality
[61]
Oral
[62]
Oral
[63]
White shrimp
Oral
Oral
Injection/
immersion
[67]
Kuruma shrimp
(Penaeus japonicus)
Black tiger shrimp
Oral
[68]
Oral
[69]
Kuruma shrimp
White shrimp
Black tiger shrimp
Black tiger shrimp
Black tiger shrimp
Intramuscular
Oral
Injection
In vitro
Oral
[70]
[71]
[72]
[73]
[74]
White shrimp
Oral
Carboxymethyl
b-1,3-glucan
b-1,3-glucan (yeast)
b-1,3-glucan (yeast)
Curdlan, zymosan
Laminarin
Crude b-1,3-glucan
(Brewers yeast)
b-1,3-glucan from
Schizophyllum
commune
Conclusion
-glucans have the potential to increase survival rates of
fish and shellfish e at least when applied as a prophylactic
measure where an injection of -glucans may induce
disease resistance. Especially for shellfish, -glucan containing diets may be an interesting option to increase
defence activity thereby disease resistance. One promising
aspect is its potential to activate fish Th17 cells that, in
turn, may increase mucosal disease resistance. The adjuvant effects possessed by some -glucans should be
addressed further. A major challenge is to reveal the
[65]
[66]
[77]
Acknowledgements
The financial support of the European Commission, grant
IMAQUANIM (contract no. 007103), the NANOMAT program
(contract no. 182035) and RCN FISHVACCPLAT (contract
no. 172508/S40) of the Research Council of Norway is highly
acknowledged.
References
[1] Aderem A, Ulevitch RJ. Toll-like receptors in the induction of
the innate immune response. Nature 2000;406:782e7.
[2] OHagan DT, MacKichan ML, Singh M. Recent developments in
adjuvants for vaccines against infectious diseases. Biomol Eng
2001;18:69e85.
[3] Schijns VEJC. Mechanisms of vaccine adjuvant activity:
initiation and regulation of immune responses by vaccine
adjuvants. Vaccine 2003;21:829e31.
[4] Bricknell IR, Dalmo RA. The use of immunostimulants in fish
larval aquaculture. Fish Shellfish Immunol 2005;19:457e72.
[5] Sakai M. Current research status of fish immunostimulants.
Aquaculture 1999;172:63e92.
394
[6] Cook MT, Hayball PJ, Hutchinson W, Nowak BF, Hayball JD.
Administration of a commercial immunostimulant preparation, EcoActivaTM as a feed supplement enhances macrophage
respiratory burst and growth rate of snapper (Pagrus auratus,
Sparidae (Bloch and Schneider)) in winter. Fish Shellfish
Immunol 2003;14:333e45.
[7] Misra CK, Das BK, Mukherjee SC, Pattnaik P. Effect of long
term administration of dietary -glucan on immunity, growth
and survival of Labeo rohita fingerlings. Aquaculture 2006;
255:82e94.
[8] Ai Q, Mai K, Zhang L, Tan B, Zhang W, Xu W, et al. Effects of
dietary -1,3 glucan on innate immune response of large
yellow croaker, Pseudosciaena crocea. Fish Shellfish Immunol
2007;22:394e402.
[9] Sealey WM, Barrows FT, Hang A, Johansen KA, Overturf K,
LaPatra SE, et al. Evaluation of the ability of barley genotypes containing different amounts of -glucan to alter
growth and disease resistance of rainbow trout Oncorhynchus mykiss. Animal Feed Science and Technology 2008;
141:115e28.
[10] Whittington R, Lim C, Klesius PH. Effect of dietary -glucan
levels on the growth response and efficacy of Streptococcus
iniae vaccine in Nile tilapia, Oreochromis niloticus. Aquaculture 2005;248:217e25.
[11] Bagni M, Romano N, Finola MG, Abelli L, Scapigliati G,
Tiscar PG, et al. Short- and long-term effects of a dietary
yeast beta-glucan (Macrogard) and alginic acid (Ergosan) preparation on immune response in sea bass (Dicentrarchus
labrax). Fish Shellfish Immunol 2005;18:311e25.
[12] Welker TL, Lim C, Yildrim-Aksoy M, Shelby R, Klesius PH.
Immune response and resistance to stress and Edwardsiella
ictaluri challenge in channel catfish, Ictalurus punctatus, fed
diets containing commercial whole-cell or yeast subcomponents. J World Aquac Soc 2007;38:24e35.
[13] Conceicao LEC, Skjermo J, Skja
k-Braek G, Verreth JAJ. Effect
of an immunostimulating alginate on protein turnover of turbot (Scophthalmus maximus L.) larvae. Fish Physiol Biochem
2001;24:207e12.
[14] Vollstad D, Bgwald J, Ga
serd O, Dalmo RA. Influence of
high-M alginate on the growth and survival of Atlantic cod
(Gadus morhua L.) and spotted wolffish (Anarhichas minor
Olafsen) fry. Fish Shellfish Immunol 2006;20:548e61.
[15] Skjermo J, Storseth TR, Hansen K, Handa A, ie G. Evaluation
of beta-(1-3,1-6)-glucans and high-M alginate used as immunostimulatory dietary supplement during first feeding and
weaning of Atlantic cod (Gadus morhua L.). Aquaculture
2006;261:1088e101.
[16] Choudhury D, Pal AK, Sahu NP, Kumar S, Das SS, Mukherjee SC.
Dietary yeast RNA supplementation reduces mortality by
Aeromonas hydrophila in rohu (Labeo rohita L.) juveniles.
Fish Shellfish Immunol 2005;19:281e91.
[17] Li P, Gatlin III DM. Nucleotide nutrition in fish: current
knowledge and future applications. Aquaculture 2006;251:
141e52.
[18] Guttvik A, Paulsen B, Dalmo RA, Espelid S, Lund V, Bgwald J.
Oral administration of lipopolysaccharide to Atlantic salmon
(Salmo salar L.) fry. Uptake, distribution, influence on growth
and immune stimulation. Aquaculture 2002;214:35e53.
[19] Bagni M, Archetti L, Amadori M, Marino G. Effect of long-term
administration of an immunostimulant diet on immunity in sea
bass (Dicentrarchus labrax). J Vet Med B Infect Dis Vet Public
Health 2000;47:745e51.
[20] Verlhac V, Obach A, Gabaudan J, Schu
ep W, Hole R. Immunomodulation by dietary vitamin C and glucan in rainbow trout (Oncorhynchus mykiss). Fish Shellfish Immunol 1998;8:409e24.
[21] Selvaraj V, Sampath K, Sekar V. Administration of yeast
glucan enhances survival and some non-specific and specific immune parameters in carp (Cyprinus carpio) infected
[22]
[23]
[24]
[25]
[26]
[27]
[28]
[29]
[30]
[31]
[32]
[33]
[34]
[35]
[36]
[37]
[38]
-glucans in aquaculture
[39]
[40]
[41]
[42]
[43]
[44]
[45]
[46]
[47]
[48]
[49]
[50]
[51]
[52]
[53]
[54]
[55]
[56]
[57]
[58]
395
[59]
[60]
[61]
[62]
[63]
[64]
[65]
[66]
[67]
[68]
[69]
[70]
[71]
[72]
[73]
[74]
396
[75] Van Hulten MCW, Witteveldt J, Snippe M, Vlak JM. White spot
syndrome virus envelope protein VP28 is involved in the
systemic infection of shrimp. Virology 2001;285:228e33.
[76] Wang YC, Chang PS, Chen HY. Tissue expressions of nine genes
important to immune defence of the Pacific white shrimp Litopenaeus vannamei. Fish Shellfish Immunol 2007;23:1161e77.